Diagnosis and treatment of insomnia (Q56084266)

American Journal of Health-System Pharmacy

Europe PubMed Central

title

Diagnosis and treatment of insomnia (English)

0 references

0 references

0 references

S. Passarella

1

0 references

M.-T. Duong

series ordinal

2

0 references

publication date

15 May 2008

0 references

published in

0 references

volume

65

0 references

issue

10

0 references

page(s)

927-934

0 references

cites work

Risk factors associated with complaints of insomnia in a general adult population. Influence of previous complaints of insomnia

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Diagnosis and treatment of chronic insomnia: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Clinical practice. Chronic insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Prevalence, burden, and treatment of insomnia in primary care

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Sleep problems and their correlates in a working population

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Primary insomnia: a risk factor to develop depression?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Current patterns and future directions in the treatment of insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Chronic benzodiazepine usage and withdrawal in insomnia patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Sleep promoters and insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Zolpidem dependence case series: possible neurobiological mechanisms and clinical management

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Amnestic sleep-related eating disorder associated with zolpidem

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Sleepwalking associated with zolpidem

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Measuring outcomes in randomized clinical trials of insomnia treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Quality of life in sleep disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640

Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060640